Search - tctmd.com

Displaying 21 - 40 of 242

Sort: Relevancy | Date

Presentation TCT 2024

TCT 28: Target Vessel Revascularization and Amputation After Chronic Limb-Threatening Ischemia Across Race Among Medicare Beneficiaries

Presenter: Joseph Kim

October 27, 2024

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

L.A. McKeown

August 26, 2024

News Daily News

Platelet Hyperreactivity Score May Improve CVD Risk Detection

L.A. McKeown

August 23, 2024

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

L.A. McKeown

August 19, 2024

News Daily News

Amputation Risks Higher After Revascularization in Younger vs Older PAD Patients

L.A. McKeown

July 24, 2024

News Daily News

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

L.A. McKeown

May 17, 2024

News Conference News SCAI 2024

No Sex-Specific Differences in PAD Therapy Outcomes: REVIVE Analysis

L.A. McKeown

May 10, 2024

News Daily News

FDA Approves Bioresorbable Scaffold for BTK Lesions

Michael O'Riordan

April 29, 2024

News Daily News

BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI

L.A. McKeown

April 24, 2024

News Daily News

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

L.A. McKeown

March 25, 2024

News Conference News CRT 2024

CLIPPER: Emphasis on Faster Revascularization Could Change CLTI Care

L.A. McKeown

March 20, 2024

News Conference News ISET 2024

How to Reconcile BEST-CLI and BASIL-2? A ‘Patient-First’ Strategy

Caitlin E. Cox

January 24, 2024

News Daily News

Top Endovascular News of 2023

L.A. McKeown

December 28, 2023

News Conference News VIVA 2023

PROMISE II: Deep-Vein Arterialization Durable for Amputation-Free Survival in CLTI

L.A. McKeown

November 01, 2023

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

Presentation TCT 2023

Intentional Coronary Revascularization Versus Conservative Therapy in Patients, who Underwent Successful Peripheral Artery Revascularization due to Critical Limb Ischemia - the INCORPORATE Randomized Clinical Trial

Presenter: Gabor Toth

October 25, 2023

Presentation TCT 2023

TCT 1001: Radial to pedal and retrograde approach for endovascular revascularization of long segment iliac- popliteal artery occlusion and chronic limb threatening ischemia

Presenter: Sonal Pruthi

October 25, 2023

Presentation TCT 2023

TCT 584: Outcomes of Endovascular Revascularization Therapy in Patients With Critical Limb Ischemia Admitted on the Weekend

Presenter: Nameer Ascandar

October 24, 2023

Presentation TCT 2023

TCT 243: Early Risk of Major Adverse Limb Events Following Lower Extremity Revascularization in the VOYAGER-PAD Trial

Presenter: R. Kevin Rogers

October 24, 2023

News Daily News

AHA Scientific Statement Urges Incorporation of Mental Health Care in PAD

L.A. McKeown

October 06, 2023

Advertisement

TCT 28: Target Vessel Revascularization and Amputation After Chronic Limb-Threatening Ischemia Across Race Among Medicare Beneficiaries

Scientific Statement Reviews Current Antithrombotic Options in PAD

Platelet Hyperreactivity Score May Improve CVD Risk Detection

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

Amputation Risks Higher After Revascularization in Younger vs Older PAD Patients

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

No Sex-Specific Differences in PAD Therapy Outcomes: REVIVE Analysis

FDA Approves Bioresorbable Scaffold for BTK Lesions

BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

CLIPPER: Emphasis on Faster Revascularization Could Change CLTI Care

How to Reconcile BEST-CLI and BASIL-2? A ‘Patient-First’ Strategy

Top Endovascular News of 2023

PROMISE II: Deep-Vein Arterialization Durable for Amputation-Free Survival in CLTI

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

Intentional Coronary Revascularization Versus Conservative Therapy in Patients, who Underwent Successful Peripheral Artery Revascularization due to Critical Limb Ischemia - the INCORPORATE Randomized Clinical Trial

TCT 1001: Radial to pedal and retrograde approach for endovascular revascularization of long segment iliac- popliteal artery occlusion and chronic limb threatening ischemia

TCT 584: Outcomes of Endovascular Revascularization Therapy in Patients With Critical Limb Ischemia Admitted on the Weekend

TCT 243: Early Risk of Major Adverse Limb Events Following Lower Extremity Revascularization in the VOYAGER-PAD Trial

AHA Scientific Statement Urges Incorporation of Mental Health Care in PAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content